Jialin Bian

Title: Jialin Bian: Innovator in Pharmaceutical Development

Introduction

Jialin Bian is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving drug delivery systems to enhance patient outcomes.

Latest Patents

Jialin Bian holds a patent for an oral solid tablet comprising Bruton's Tyrosine Kinase inhibitor and its preparation method. The patent describes an oral solid tablet that includes (S)-7-[4-(1-acryloylpiperidine)]-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide. This formulation exhibits excellent drug release characteristics, ensuring easy administration and quick, efficient release. The preparation process is straightforward, requiring no special equipment, which contributes to formulation stability and facilitates transportation and storage. This innovation is particularly suitable for large-scale production.

Career Highlights

Jialin Bian is currently associated with BeiGene Switzerland GmbH, where he continues to advance his research and development efforts in the pharmaceutical industry. His expertise in drug formulation has positioned him as a key player in the field.

Collaborations

Jialin collaborates with talented colleagues, including Gang Qiu and Yiwei Shen, who contribute to his innovative projects and research initiatives.

Conclusion

Jialin Bian's contributions to pharmaceutical innovations, particularly through his patented oral solid tablet, highlight his commitment to improving drug delivery systems. His work not only enhances patient care but also paves the way for future advancements in the industry.